Gore Acquires Intellectual Property of NMT Medical, Inc.

19 October 2011 (Flagstaff, Arizona)

CLOSURE I Trial Data May Create Better Clinical Understanding of Patent Foramen Ovale (PFO) in Stroke Patients

W. L. Gore & Associates (Gore) today announced that the Company has purchased the assets and intellectual property of NMT Medical, Inc., including the data related to CLOSURE I, a prospective, multi-center, randomized controlled trial of PFO closure with the STARFLEX® Device (NMT Medical, Inc) versus best medical therapy for the prevention of recurrent stroke and /or transient ischemic attack (TIA) in patients with cryptogenic stroke / TIA and PFO.

“We made the decision to acquire these assets in the spirit of collaboration and in the interest of advancing scientific and medical understanding,” said Stuart Broyles, PhD, Associate with the Gore Medical Division Stroke Business. The study data were acquired with the rest of the NMT assets, but the transaction did not transfer any liabilities or regulatory obligations of NMT.

The acquisition came after NMT ceased operations earlier this year.


The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for three decades. During that time, more than 30 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 14th consecutive year.

Products listed may not be available in all markets. GORE® and designs are trademarks of W. L. Gore & Associates. © 2011 W. L. Gore & Associates, Inc.